Ideal Depth of Guide Wire for Central Catheterization

July 8, 2016 updated by: Jung-Man Lee, Seoul National University Hospital

Ideal Depth of Guide Wire for Right Internal Jugular Vein During Central Line Insertion

prospective randomized double-blind controlled study

Study Overview

Detailed Description

Total of 69 ASA (American Society of Anesthesiologist) physical status class I or II patients will be enrolled.

Randomly assigned to three group according to the depth of guide-wire prior to tissue dilation during central catheterization via right internal jugular vein. (Group 1: 15 cm / Group 2: 17.5 cm / Group 3: 20 cm)

Central catheterization will be performed by anesthesiologists who be blinded to this study protocol.

An investigator will monitor and record whether any arrhythmia will occur.

The incidence of occurrence of arrhythmia will be compared between three groups.

Study Type

Interventional

Enrollment (Actual)

69

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients receiving general anesthesia requiring central venous catheterization via right internal jugular vein.
  • ASA (American Society of Anesthesiologist) physical status class I or II

Exclusion Criteria:

  • at the pre-anesthetic evaluation, history of any arrhythmia
  • when monitoring before the induction of anesthesia in the operating room, newly arrhythmia is observed.
  • abnormal electrolyte at the pre-anesthetic evaluation
  • too difficult to access right internal jugular vein for central catheterization (too short neck, infection at the site of right internal jugular vein, ventriculoperitoneal shunt or chemo-port existence at the site of right internal jugular vein. too close site to operating field)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 15 cm
The depth of guide wire will be 15 cm from puncture site of skin prior to tissue dilation during central venous catheterization

15 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 15 cm.

17.5 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 17.5 cm.

20 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 20 cm.

Experimental: 17.5 cm
The depth of guide wire will be 17.5 cm from puncture site of skin prior to tissue dilation during central venous catheterization

15 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 15 cm.

17.5 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 17.5 cm.

20 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 20 cm.

Active Comparator: 20 cm
The depth of guide wire will be 20 cm from puncture site of skin prior to tissue dilation during central venous catheterization

15 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 15 cm.

17.5 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 17.5 cm.

20 cm: The depth of guide wire prior to tissue dilation during central venous catheterization will be 20 cm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Incidence of arrhythmia
Time Frame: during central venous catheterization
during central venous catheterization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Jung-Man Lee, M.D., Seoul National University Boramae Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

May 1, 2016

Study Registration Dates

First Submitted

March 14, 2016

First Submitted That Met QC Criteria

March 14, 2016

First Posted (Estimate)

March 17, 2016

Study Record Updates

Last Update Posted (Estimate)

July 11, 2016

Last Update Submitted That Met QC Criteria

July 8, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 16-2015-105

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patient Safety During Central Venous Catheterization

Clinical Trials on central venous catheterization

3
Subscribe